Bioprocessing Reimagined
Isolere Bio delivers manufacturing solutions that accelerate therapeutic development, harmonize commercial scaling, and improve global access to life changing medicines and vaccines.
Isolere Bio was founded in 2017 with the vision of re-imagining the manufacturing of biologics. Donaldson, with its own vision for bringing its history of filtration innovation to the life sciences industry, saw our value and acquired the company in 2023. We are now part of a portfolio of solutions addressing major biomanufacturing bottlenecks with novel, scalable solutions and close partnership with our customers.
Our Mission
Accelerate the development of therapeutics to improve human health and global accessibility
We develop bioprocesses that improve product quality, reduce waste, and scale linearly. Isolere Bio is committed to bringing life-changing therapies to patients around the globe more quickly and more affordably.
Our Niche
Develop and deliver reagents and accompanying processes that streamline manufacturing
We innovate in the bioprocessing space by bringing all available technologies together in a highly cross-functional environment to streamline the production of biologics.
The newly defined Donaldson Life Sciences division is building a portfolio of biopharma innovations to provide cutting-edge technologies that simplify and accelerate development and production of therapeutics.
We are leveraging Donaldson’s over 100-year legacy as a global leader in filtration solutions and customer-centric service. We solve the world's most complex filtration challenges, and now are working to revolutionize solutions for biopharmaceutical applications.
Our strategy is underpinned by developing critical filtration, purification, and separation technologies that service the discovery, development, and GMP production of biopharmaceuticals. Isolere Bio, Purilogics, Solaris Biotech, and Univercells Technologies work together to provide differentiated solutions for advanced therapeutic bioprocessing, while also consolidating multiple steps in the bioprocessing value-chain. We work with you, innovate, and deliver.
Isolere Bio
We are our people.
The Isolere Bio Leadership Team
Dion Aviki
-
Dion holds a Bachelor of Science in Chemical Engineering from Auburn University and an MBA from Duke University’s Fuqua School of Business.
She joins the Isolere Bio team, bringing over two decades of diverse leadership experience spanning key commercial functions including sales, commercial excellence, product management, business development and strategy.
Michael Dzuricky
-
Mike attended Duke University to earn his PhD in Biomedical Engineering, publishing over 20 co-authored research papers and filing 2 patents during his tenure.
After taking over as Chief Scientific Officer at Isolere Bio in 2019, Mike has been responsible for the technological development of Isolere Bio core products, responsible for growing the research and operations department from 3 to over 20 employees and submitting numerous successful grant applications to various funding agencies, including NIH and BARDA.
Now, a Director of R&D with Donaldson Company, Mike is focused on expanding the pipeline of the Donaldson Life Science business and bringing innovations from concept to prototype.
Eugene Kang
-
Eugene holds a Bachelor’s degree from the University of Notre Dame, a Master of Public Health from Columbia University, and an MBA from Boston University.
He joins Isolere Bio with nearly two decades in the life sciences tools sector and academic research space. This includes cross-functional roles in product management, program management, and market development for industry association award-winning product launches in the GMP clinical space.
Eugene's focus areas involve product innovation, organic and inorganic market expansion initiatives, as well as continuous improvement as Product Management leader for Isolere Bio.
Kimberly Anderson
-
Kimberly received her PhD in Marine Estuarine Environmental Sciences from the University of Maryland College Park, where she specialized in microbiology and biotechnology. She has 15 years of experience in developing and scaling biologically-based processes from bench scale to production scale. Her experience includes fermentation optimization as well as downstream purification process optimization for commercialization of products in food, personal care, energy, advance materials, and pharmaceutical industries.
As Director of Commercial R&D at Isolere, Kim is responsible for leading products from prototype to commercial launch at higher grades and larger scale of more regular batch production.
Life Science Technical Center
Isolere Bio is located in an Alexandria Center in Research Triangle Park (RTP), a hub where many biotechnology and cell and gene therapy companies come together. This close proximity allows for collaboration, learning, and conferences between scientists. The campus hosts a number of benefits, including fitness amenities, an on-site restaurant and bar, and paved nature trails leading throughout RTP.
Located between Durham, Raleigh, Chapel Hill, and Cary, our 24,000 sq ft facility features cutting edge equipment allowing for the research, process and application development, and manufacturing of recombinant proteins. ISO 9001 certified since 2025, our facility houses six laboratory spaces as well as an ISO 7 capable clean room environment in our 6,000 sq ft manufacturing suite.
Integrity. Inclusion. Innovation.
Pride in our people and a passion for what we’re building together.
At Isolere, we want to foster a meritocratic workplace where the best ideas win and mutual respect is non-negotiable. Regularly scheduled social and volunteering events are prioritized to build close working relationships outside the lab and office, as well as to better our local community. Come join a team of innovative, kindhearted people that believe in Isolere’s founding mission of accelerating and improving global access to life changing medicines.